Cargando…

The clinical relative biological effectiveness and prostate‐specific antigen kinetics of carbon‐ion radiotherapy in low‐risk prostate cancer

BACKGROUND: To evaluate the clinical relative biological effectiveness (RBE) of carbon‐ion radiotherapy (C‐ion RT) for prostate cancer. METHODS: The records of 262 patients with low‐risk prostate cancer (median age, 65 [47–80] years) treated with C‐ion RT at QST Hospital, National Institutes for Qua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Yu‐Mei, Ishikawa, Hitoshi, Inaniwa, Taku, Iwai, Yuma, Matsufuji, Naruhiro, Kasuya, Goro, Okonogi, Noriyuki, Liu, Yu‐Ming, Chao, Yee, Wakatsuki, Masaru, Tsujii, Hirohiko, Tsuji, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883571/ https://www.ncbi.nlm.nih.gov/pubmed/35852142 http://dx.doi.org/10.1002/cam4.5045

Ejemplares similares

Five-year quality of life assessment after carbon ion radiotherapy for prostate cancer
por: Maruyama, Katsuya, et al.
Publicado: (2017)

Safety and Efficacy of Carbon-Ion Radiotherapy for Elderly Patients with High-Risk Prostate Cancer
por: Hiroshima, Yuichi, et al.
Publicado: (2022)

Long‐term clinical outcomes after 12‐fractionated carbon‐ion radiotherapy for localized prostate cancer
por: Sato, Hiraku, et al.
Publicado: (2021)

Significant impact of biochemical recurrence on overall mortality in patients with high‐risk prostate cancer after carbon‐ion radiotherapy combined with androgen deprivation therapy
por: Kasuya, Goro, et al.
Publicado: (2016)

Identification of Early Biochemical Recurrence Predictors in High-Risk Prostate Cancer Patients Treated with Carbon-Ion Radiotherapy and Androgen Deprivation Therapy
por: Utsumi, Takanobu, et al.
Publicado: (2023)

Cancer‐specific mortality of high‐risk prostate cancer after carbon‐ion radiotherapy plus long‐term androgen deprivation therapy
por: Kasuya, Goro, et al.
Publicado: (2017)

Carbon‐ion radiotherapy for urological cancers
por: Ishikawa, Hitoshi, et al.
Publicado: (2022)

Carbon-ion radiotherapy for locally advanced cervical cancer with bladder invasion
por: Shiba, Shintaro, et al.
Publicado: (2016)

Clinical advantage and outcomes of computed tomography‐based transvaginal hybrid brachytherapy performed only by sedation without general or saddle block anesthesia
por: Okonogi, Noriyuki, et al.
Publicado: (2022)

Up-to-date results of carbon-ion radiotherapy for prostate cancer
por: Nomiya, Takuma, et al.
Publicado: (2014)

The Risk Factors for Radiation Pneumonitis after Single-Fraction Carbon-Ion Radiotherapy for Lung Cancer or Metastasis
por: Ono, Takashi, et al.
Publicado: (2021)

Dose prescription in carbon ion radiotherapy: How to compare two different RBE-weighted dose calculation systems
por: Molinelli, Silvia, et al.
Publicado: (2016)

Risk of secondary malignancy after radiotherapy for breast cancer: long-term follow-up of Japanese patients with breast cancer
por: Okonogi, Noriyuki, et al.
Publicado: (2022)

Dose constraints in the rectum and bladder following carbon-ion radiotherapy for uterus carcinoma: a retrospective pooled analysis
por: Okonogi, Noriyuki, et al.
Publicado: (2018)

Secondary cancers after carbon‐ion radiotherapy and photon beam radiotherapy for uterine cervical cancer: A comparative study
por: Nitta, Yuki, et al.
Publicado: (2022)

Progressive hypofractionated carbon‐ion radiotherapy for hepatocellular carcinoma: Combined analyses of 2 prospective trials
por: Kasuya, Goro, et al.
Publicado: (2017)

Kinetics of Prostate-Specific Antigen after Carbon Ion Radiotherapy for Prostate Cancer
por: Darwis, Narisa Dewi Maulany, et al.
Publicado: (2020)

Multi-Institutional Retrospective Analysis of Carbon-Ion Radiotherapy for Patients with Locally Advanced Adenocarcinoma of the Uterine Cervix
por: Okonogi, Noriyuki, et al.
Publicado: (2021)

Carbon-ion radiotherapy for inoperable endometrial carcinoma
por: Irie, Daisuke, et al.
Publicado: (2018)

Single fraction carbon ion radiotherapy for colorectal cancer liver metastasis: A dose escalation study
por: Makishima, Hirokazu, et al.
Publicado: (2018)

Comparison of passive and scanning irradiation methods for carbon-ion radiotherapy for breast cancer
por: Matsubara, Hiroaki, et al.
Publicado: (2018)

Significance of concurrent use of weekly cisplatin in carbon‐ion radiotherapy for locally advanced adenocarcinoma of the uterine cervix: A propensity score‐matched analysis
por: Okonogi, Noriyuki, et al.
Publicado: (2019)

Optimizing 3DCT image registration for interfractional changes in carbon-ion prostate radiotherapy
por: Hirai, Ryusuke, et al.
Publicado: (2023)

Long Term Results of Single-Fraction Carbon-Ion Radiotherapy for Non-small Cell Lung Cancer
por: Ono, Takashi, et al.
Publicado: (2020)

Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer
por: Hayashi, Kazuhiko, et al.
Publicado: (2017)

Selection of carbon beam therapy: biophysical models of carbon beam therapy
por: Matsufuji, Naruhiro
Publicado: (2018)

Long-Term Outcomes of Carbon-Ion Radiotherapy for Malignant Gynecological Melanoma
por: Murata, Hiroto, et al.
Publicado: (2019)

Clinical impact of carbon‐ion radiotherapy on hepatocellular carcinoma with Child‐Pugh B cirrhosis
por: Hiroshima, Yuichi, et al.
Publicado: (2023)

The effects of PSA kinetics on the outcome of hypofractionated salvage radiotherapy for biochemical recurrence of prostate cancer after prostatectomy
por: Ishikawa, Hitoshi, et al.
Publicado: (2020)

Event-by-event approach to the oxygen-effect-incorporated stochastic microdosimetric kinetic model for hypofractionated multi-ion therapy
por: Inaniwa, Taku, et al.
Publicado: (2023)

Long-Term Results of High-Dose 2-Fraction Carbon Ion Radiation Therapy for Hepatocellular Carcinoma
por: Yasuda, Shigeo, et al.
Publicado: (2019)

Risk factors for rectal bleeding associated with I-125 brachytherapy for prostate cancer
por: Harada, Kosaku, et al.
Publicado: (2012)

Clinical Trial of Prophylactic Extended-Field Carbon-Ion Radiotherapy for Locally Advanced Uterine Cervical Cancer (Protocol 0508)
por: Wakatsuki, Masaru, et al.
Publicado: (2015)

Correction: Clinical Trial of Prophylactic Extended-Field Carbon-Ion Radiotherapy for Locally Advanced Uterine Cervical Cancer (Protocol 0508)
por: Wakatsuki, Masaru, et al.
Publicado: (2015)

Clinical outcomes of carbon ion radiotherapy with concurrent chemotherapy for locally advanced uterine cervical adenocarcinoma in a phase 1/2 clinical trial (Protocol 1001)
por: Okonogi, Noriyuki, et al.
Publicado: (2018)

A Review of Update Clinical Results of Carbon Ion Radiotherapy
por: Tsujii, Hirohiko, et al.
Publicado: (2012)

Prostate-specific antigen kinetics after stereotactic body radiotherapy as monotherapy or boost after whole pelvic radiotherapy for localized prostate cancer
por: Kim, Hun Jung, et al.
Publicado: (2015)

The Emerging Potential of Multi-Ion Radiotherapy
por: Ebner, Daniel K., et al.
Publicado: (2021)

Phase I/II trial of definitive carbon ion radiotherapy for prostate cancer: evaluation of shortening of treatment period to 3 weeks
por: Nomiya, T, et al.
Publicado: (2014)

Carbon ion radiotherapy in a hypofractionation regimen for stage I non-small-cell lung cancer
por: Takahashi, Wataru, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_kn5s5lt0nmkftnpmmhgp8hdv0j